COVID-19 Medical Information

From Wiki by Civil Slave

This page is for medical based information, and misinformation. For conspiracy, truth, and political aspects of the Coronavirus Pandemic please either go to that page, or create one if one does not currently exist on this wiki.

Supplements & Lifestyle

Natural Covid Preventative Measures

  • sunlight
  • light exercise
  • social interaction & connection
  • Vitamin C
  • Vitamin D (recommended to combine with Vitamin K2)
  • Zinc
  • Quercetin (yes - this is like a natural antiviral that releases the zinc ions to act as a protease inhibitor in cells with ACE2 receptors. Similar mechanism to the more powerful pharmaceutical ‘Hydroxychloroquine’)
    • "Kidney problems : Quercetin might make kidney problems worse. Don't use quercetin if you have kidney problems." ~ WebMD
  • Cysteine (naturally occurring in certain foods like; chicken, and sesame seeds) -- or supplemental form as
  • NAC (N-Ac
  • etylcysteine)
  • Selenium (good idea)
  • Iodine (certain kinds better than others, and in moderation) - possibly helps
  • Colloidal Silver (natural healthy brand, and in moderation) - natural antiviral also.

Note: cheap supermarket brands not recommended generally. Natural better healthier options are very available now, but can cost a lot of money.

Vaccine Exemption Information

How To Get COVID-19 Medication

Medical Preventatives & Treatments

Medical COVID Preventatives / Early-Stage Treatment

French Protocol

  • The “French Protocol by Dr. Raoult” (Professor Didier Raoult Publishes Results of a Hydroxychloroquine Treatment Study on 1061 Patients)

Genreally (but this is NOT medical advice).. generally the combination of lower dose Hydroxychloroquine + Azythromycin + Zinc' -- is the EARLY stage proven treatment which has been shown to effectively cures COVID-19 up to 91.7%) -- That is a cure rate of the cases either already severe or progressing to severe, out of 1061 patients. Other physicians and hospitals have duplicated this around the world.

IMPORTANT: Some people due to their medications and current health conditions may be susceptible to heart arrhythmia from the Hyroxy+Azythro combo, and should perhaps not follow that treatment, or be under very strict monitoring. Those decision and understandings should be risk/benefit discussions with their healthcare professionals.

A UK-based biotechnology firm has announced it is working alongside the University of Oxford, UK, to evaluate Evasins (molecules derived from ticks) as a potential COVID-19 treatment option for patients whose lungs are badly damaged by the virus and face a critical juncture in recovery.


Clinical Trials & Publications

  • Cytokine release syndrome in severe COVID-19 - Although the situation is rapidly evolving, severe disease manifested by fever and pneumonia, leading to acute respiratory distress syndrome (ARDS), has been described in up to 20% of COVID-19 cases.

This is reminiscent of cytokine release syndrome (CRS)–induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy. Given this experience, urgently needed therapeutics based on suppressing CRS, such as tocilizumab, have entered clinical trials to treat COVID-19.

SARS-CoV-2 is a betacoronavirus that is most closely related to SARS-CoV. Both viruses use the angiotensin-converting enzyme–related carboxypeptidase (ACE2) receptor to gain entry to cells. This receptor is widely expressed in cardiopulmonary tissues but also in some hematopoietic cells, including monocytes and macrophages.

A key feature of COVID-19 infection is lymphopenia (low blood lymphocyte count), which correlates with clinical severity. SARS-CoV efficiently infects primary human monocytes and dendritic cells, whereas MERS-CoV infects monocytes and T cells via dipeptidyl peptidase 4 (DPP4).

It is possible that SARS-CoV-2 also infects dendritic cells. T cell apoptosis and exhaustion resulting from defective activation due to dendritic cell dysfunction might contribute to the immunopathology of COVID-19. However, lymphopenia as a biomarker of poor prognosis for COVID-19 is not specific because it was also a biomarker that correlated with fatality in the 2009 influenza A (H1N1) pandemic.

Hydroxychloroquine

It seems like perhaps that Ivermectin news is suppressing the effectiveness of Hydroxychloroquine. Remember the Hydroxychloroquine raw materials factory that exploded and burnt to the ground just before the Vaccine (mRNA experimental gene therapy injection) rollout.

Ivermectin

Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells. This may be related to the regulation of multiple signaling pathways by ivermectin through PAK1 kinase. On the other hand, ivermectin promotes programmed cancer cell death, including apoptosis, autophagy and pyroptosis. Ivermectin induces apoptosis and autophagy is mutually regulated. Interestingly, ivermectin can also inhibit tumor stem cells and reverse multidrug resistance and exerts the optimal effect when used in combination with other chemotherapy drugs.

Abstract

Stable isotope labeling with amino acids in cell culture (SILAC) was to use isotopic essential amino acids to replace the original amino acids for cell culture and passage for 8–10 generations, followed by mass spectrometry to identify proteins and the isotopic abundance difference to quantify proteins. SILAC can be used to characterize proteomic changes, and analyze protein turnover, protein interactions, and dynamic changes with quantitative accuracy, and high reproducibility. For this study, SILAC “light” (L-Lysine-2HCl [12C6, 14N2], L-Arginine-HCl [12C6, 14N4])- or “heavy” (L-Lysine-2HCl [13C6, 15N2], L-Arginine-HCl [13C6, 15N4])-labeling RPMI 1640 medium was used to culture human ovarian cancer TOV-21G cells for 10 passages, followed by the treatment of 0.1% dimethylsulfoxide for 24 h and 20 µM ivermectin for 24 h, respectively. The light- and heavy-isotope-labeled proteins were equally mixed (1:1) for digestion with trypsin. The tryptic peptide mixture was fractionated with liquid chromatography and analyzed with tandem mass spectrometry. In total, 4,447 proteins were identified in ivermectin-treated TOV-21G cells in relation to controls. Those proteins were enriched in 89 statistically significant signaling pathways and 62 statistically significant biological processes. These findings clearly demonstrated that SILAC quantitative proteomics was a useful and reliable method to study ivermectin-related proteomic changes in cancer cells, which in combination with molecular pathway networks and biological processes enrichments provided more comprehensive insights into molecular mechanisms of ivermectin in inhibiting TOV-21G cells.

General Virus and Vaccine Information

Covid Vaccine Health Concerns

There have been a great many cases of people suffering from post 'vaccine' blood clotting, and related health problems such as strokes and heart attacks. Some doctors say that the healthcare industry should be carrying out post-vaccine D-Dimer Blood Tests to evaluate the rate of occurrence of blood disorders following injection. It is stated by some physicians that all their patients tested with D-Dimer Tests showed signs of affected blood, and micro clots.

  • The McCullough Report - Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, New Hampshire Senate, and South Carolina Senate concerning many aspects of the pandemic response. Dr. McCullough has two years of dedicated academic and clinical efforts in combating the SARS-CoV-2 virus. In doing so, he has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and been considered among the world’s experts on COVID-19.

COVID Research - OCTOBER - December 2021

“We are dealing with evil. In case you hadn’t noticed.” – Robert W Malone, MD, Twitter

  • Vaccine Impact - Vaccine Impact is a part of the Health Impact News network. It is a sub-topic in their “Medicine Watch” category.

Error creating thumbnail: Unable to save thumbnail to destination

ARTERIOSCLEROSIS, THROMBOSIS, VASCULAR BIOLOGY
SESSION TITLE: DAMPS, INFECTION AND CARDIOVASCULAR METABOLISM

Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

Steven R Gundry
Originally published8 Nov 2021 Circulation. 2021;144:A10712
This article has an expression of concern

Expression of Concern: Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

Abstract

Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.

Retrieved from "https://wiki.civilslave.com/index.php?title=COVID-19_Medical_Information&oldid=1356"